Antineoplastilised ja immuunosupresseerivad ravimid
Contracts total
3 448 410 €
Bids
3
Type
Supplies
Published
30.11.2023
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping antineoplastiliste ja immuunosupresseerivate ravimite ostmiseks HD Lisas 1 toodud nimetuste ja kirjelduste alusel.
Awarded contracts
30.11.2023| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| L01AA01 Cyclophosphamide | AS Oribalt Tallinn | 30 180 € | 1 | 24.11.2023 |
| L01AA06 Ifosfamide | AS Oribalt Tallinn | 34 910 € | 1 | 24.11.2023 |
| L01AX03 Temozolomid | TAMRO EESTI OÜ | 2076 € | 2 | 20.11.2023 |
| L01AX03 Temozolomid | TAMRO EESTI OÜ | 1339 € | 2 | 20.11.2023 |
| L01AB01 Busulfan | TAMRO EESTI OÜ | 32 400 € | 1 | 20.11.2023 |
| L01AC01 Thiotepa | Apteegikaubanduse Hulgimüük OÜ | 60 463 € | 2 | 15.11.2023 |
| L01AC01 Thiotepa | Apteegikaubanduse Hulgimüük OÜ | 4328 € | 2 | 15.11.2023 |
| L01BA01 Methotrexat | First Pharma OÜ | 24 600 € | 2 | 20.11.2023 |
| L01BB04 Kladribiin | MAGNUM MEDICAL OÜ | 15 356 € | 2 | 20.11.2023 |
| L01BC01 Cytarabine | Apteegikaubanduse Hulgimüük OÜ | 17 328 € | 2 | 15.11.2023 |
| L01BC02 Fluorouracil | First Pharma OÜ | 69 000 € | 3 | 20.11.2023 |
| L01BC05 Gemcitabine | Apteegikaubanduse Hulgimüük OÜ | 78 800 € | 1 | 15.11.2023 |
| L01CA02 Vincristin | TAMRO EESTI OÜ | 2976 € | 3 | 20.11.2023 |
| L01CB01 Etoposide | OÜ Chirurgicus | 23 400 € | 1 | 15.11.2023 |
| L01CB01 Etoposide | First Pharma OÜ | 52 920 € | 1 | 20.11.2023 |
| L01CD01 Paclitaxel | TAMRO EESTI OÜ | 44 400 € | 1 | 20.11.2023 |
| L01DB01 Doxorubicin | OÜ Chirurgicus | 22 400 € | 1 | 15.11.2023 |
| L01DB02 Daunorubicin | MAGNUM MEDICAL OÜ | 15 135 € | 2 | 20.11.2023 |
| L01DB07 Mitoxantrone | AS Oribalt Tallinn | 9088 € | 1 | 24.11.2023 |
| L01DC01 Bleomycin | Apteegikaubanduse Hulgimüük OÜ | 24 700 € | 1 | 15.11.2023 |
| L01DC03 Mitomycin | Apteegikaubanduse Hulgimüük OÜ | 36 160 € | 1 | 15.11.2023 |
| L01DC03 Mitomycin | Apteegikaubanduse Hulgimüük OÜ | 11 542 € | 1 | 15.11.2023 |
| L01EF01 Cetuximab | TAMRO EESTI OÜ | 10 301 € | 1 | 20.11.2023 |
| L01XA01 Cisplatin | MAGNUM MEDICAL OÜ | 63 000 € | 1 | 20.11.2023 |
| L01XA02 Carboplatin | Apteegikaubanduse Hulgimüük OÜ | 57 740 € | 2 | 15.11.2023 |
| L01XA03 Oxaliplatin | Apteegikaubanduse Hulgimüük OÜ | 54 824 € | 2 | 15.11.2023 |
| L01XF01 Tretionin | TAMRO EESTI OÜ | 11 866 € | 3 | 20.11.2023 |
| L01XC12 Bentruximab vedotin | MAGNUM MEDICAL OÜ | 218 021 € | 1 | 20.11.2023 |
| L01XC80 Beetadinutuksimaab | TAMRO EESTI OÜ | 221 600 € | 1 | 20.11.2023 |
| L01XX02 Asparaginase | Apteegikaubanduse Hulgimüük OÜ | 45 185 € | 2 | 15.11.2023 |
| L01EG01 Temsirolimus | TAMRO EESTI OÜ | 73 570 € | 1 | 20.11.2023 |
| L01EB03 Afatinib | MAGNUM MEDICAL OÜ | 125 616 € | 2 | 20.11.2023 |
| L01EB03 Afatinib | MAGNUM MEDICAL OÜ | 125 672 € | 2 | 20.11.2023 |
| L01CE01 Topotecan | MAGNUM MEDICAL OÜ | 34 000 € | 1 | 20.11.2023 |
| L01CE02 Irinotecan | Apteegikaubanduse Hulgimüük OÜ | 27 159 € | 2 | 15.11.2023 |
| L01EX09 Nintedanib | TAMRO EESTI OÜ | 17 862 € | 2 | 20.11.2023 |
| L01XG03 Ixazomib | MAGNUM MEDICAL OÜ | 168 256 € | 1 | 20.11.2023 |
| L01XG03 Ixazomib | MAGNUM MEDICAL OÜ | 168 256 € | 1 | 20.11.2023 |
| L03AX03 BCG vaccine | Apteegikaubanduse Hulgimüük OÜ | 55 970 € | 1 | 15.11.2023 |
| L03AX15 Mifamurtid | MAGNUM MEDICAL OÜ | 56 328 € | 1 | 20.11.2023 |
| L04AA04 Anti-T-lymphocyte immunoglobulin | MAGNUM MEDICAL OÜ | 227 071 € | 2 | 20.11.2023 |
| L04AA06 Mükofenoolhape | Roche Eesti Osaühing | 21 560 € | 1 | 20.11.2023 |
| L04AA06 Mükofenoolhape | MAGNUM MEDICAL OÜ | 4634 € | 3 | 20.11.2023 |
| L04AA27 Fingolimod | MAGNUM MEDICAL OÜ | 239 496 € | 2 | 20.11.2023 |
| L04AA33 Vedolizumab | MAGNUM MEDICAL OÜ | 766 556 € | 1 | 20.11.2023 |
| L04AD02 Tacrolimus | MAGNUM MEDICAL OÜ | 2573 € | 2 | 20.11.2023 |
| L04AD02 Tacrolimus | TAMRO EESTI OÜ | 13 880 € | 2 | 20.11.2023 |
| L04AX02 Talidomiid | TAMRO EESTI OÜ | 23 914 € | 1 | 20.11.2023 |
Tender lots
56| Lot | Estimated value | Deadline |
|---|---|---|
| L01AA01 Cyclophosphamide | ||
| L01AA03 Melphalan | ||
| L01AA06 Ifosfamide | ||
| L01AX03 Temozolomid | ||
| L01AX03 Temozolomid | ||
| L01AB01 Busulfan | ||
| L01AC01 Thiotepa | ||
| L01AC01 Thiotepa | ||
| L01BA01 Methotrexat | ||
| L01BA01 Methotrexat | ||
| L01BB04 Kladribiin | ||
| L01BB05 Fludarabine | ||
| L01BC01 Cytarabine | ||
| L01BC02 Fluorouracil | ||
| L01BC05 Gemcitabine | ||
| L01CA04 Vinorelbine | ||
| L01CA01 Vinblastin | ||
| L01CA02 Vincristin | ||
| L01CB01 Etoposide | ||
| L01CB01 Etoposide | ||
| L01CD01 Paclitaxel | ||
| L01DB01 Doxorubicin | ||
| L01DB02 Daunorubicin | ||
| L01DB03 Epirubicin | ||
| L01DB06 Idarubicin | ||
| L01DB07 Mitoxantrone | ||
| L01DC01 Bleomycin | ||
| L01DC03 Mitomycin | ||
| L01DC03 Mitomycin | ||
| L01EF01 Cetuximab | ||
| L01XA01 Cisplatin | ||
| L01XA02 Carboplatin | ||
| L01XA03 Oxaliplatin | ||
| L01XF01 Tretionin | ||
| L01XC12 Bentruximab vedotin | ||
| L01XC80 Beetadinutuksimaab | ||
| L01XX02 Asparaginase | ||
| L01EG01 Temsirolimus | ||
| L01EB03 Afatinib | ||
| L01EB03 Afatinib | ||
| L01CE01 Topotecan | ||
| L01CE02 Irinotecan | ||
| L01EX09 Nintedanib | ||
| L01XG03 Ixazomib | ||
| L01XG03 Ixazomib | ||
| L03AX03 BCG vaccine | ||
| L03AX15 Mifamurtid | ||
| L04AA04 Anti-T-lymphocyte immunoglobulin | ||
| L04AA06 Mükofenoolhape | ||
| L04AA06 Mükofenoolhape | ||
| L04AA27 Fingolimod | ||
| L04AA33 Vedolizumab | ||
| L04AD02 Tacrolimus | ||
| L04AD02 Tacrolimus | ||
| L04AD02 Tacrolimus | ||
| L04AX02 Talidomiid |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 tomorrowEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 tomorrowEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 2 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 4 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 8 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 8 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.